Characterization of monoaminergic receptors in hypothalamic nuclei mediating feeding behavior in rats.
It has been proposed that receptors mediating the action of dopamine (DA), serotonin and norepinephrine exist in the hypothalamus to control feeding behavior in the rat. To further characterize the receptor subtypes involved in this phenomenon and determine their locus within specific hypothalamic nuclei, measurements of adenylate cyclase (AC) activity, as a biochemical index of monoaminergic receptors, were taken after administration of various monoaminergic agonists and antagonists. It was first found that DA and selective D2 agonists, such as quinpirole and lisuride, strongly reduced AC activity in homogenates from the lateral perifornical hypothalamus (PFH), where previous evidence has shown DA agonists to inhibit feeding. These inhibitory effects were stereospecifically antagonized by the D2 antagonist (-)-sulpiride. The selective D1 agonist SKF 82526, up to 100 microM, was completely inactive in modifying the basal enzyme function in PFH. In homogenates from rat paraventricular nucleus (PVN), DA (100 microM), quinpirole (10 microM) and SKF 82526 (100 microM) were unable to affect AC activity, consistent with previous pharmacological evidence showing DA in the PVN to have no effect on feeding. These results suggest the presence of D2 receptors in the PFH but not in the PVN and the absence of D1 receptors in both areas. Under the same experimental conditions, the alpha 2 adrenoceptor agonist clonidine was able to inhibit AC in the PVN, and this effect was reversed by the alpha adrenoceptor antagonist phenoxybenzamine. These results supported the previously described PVN alpha 2 adrenergic system.(ABSTRACT TRUNCATED AT 250 WORDS)
Carruba
M O
MO
Department of Biomedical Sciences and Biotechnologies, School of Medicine, University of Brescia, Italy.
Nisoli
E
E
Garosi
V
V
Pizzi
M
M
Memo
M
M
Spano
P
P
D000262:Adenylyl Cyclases / Q000378:metabolism*; D000818:Animals; D001552:Benzazepines / Q000494:pharmacology; D015306:Biogenic Monoamines / Q000494:pharmacology*; D015259:Dopamine Agents / Q000494:pharmacology; D005247:Feeding Behavior / Q000187:drug effects*; D007031:Hypothalamus / Q000187:drug effects* / Q000201:enzymology; D007276:Injections, Intraventricular; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine / Q000145:classification / Q000187:drug effects*
D001552:Benzazepines; D015306:Biogenic Monoamines; D015259:Dopamine Agents; D011954:Receptors, Dopamine; D000262:Adenylyl Cyclases